Background In many middle-income countries, there is limited data available to evaluate the effectiveness of non-communicable disease (NCD) programmes. Since 1970, three neighbouring middle-income countries-Argentina, Chile and Uruguayhave undergone health sector reforms and reorganized their NCD programmes. In this paper, we explore whether data on premature adult mortality can be used to gauge the effectiveness of these programmes.
Introduction
Chronic disease represents over half of the burden of disease in most middle-income countries and the proportion of deaths from non-communicable chronic diseases 1 (NCD) is expected to increase in coming decades (Mathers and Loncar 2006) . Health systems in middle-income countries are reorienting their resources and developing policies and programmes to respond to the growing cost and prevalence of NCD (Anderson and Chu 2007) . Information systems that can be used to evaluate the impact of these policies and programmes are also beginning to emerge, but generally, longitudinal data are not yet available in many low-and middle-income countries. This makes evaluation of their NCD programmes problematic. However, many middle-income countries have reliable vital statistics that could be used to conduct a preliminary assessment of whether the NCD programmes are having any impact on mortality rates. A common assumption is that NCD predominately affect the old, yet data from many middle-income countries show that a significant percentage of adults aged 15-59 are also likely to experience NCD and that the impact of NCD in this population has significant economic and social costs (WHO 2005) . As middle-income countries respond to an increased demand for services from the working age population with chronic conditions, there is often a reorientation of health care and prevention policies. Health care systems, initially developed to deal with infectious diseases and maternal and child health, now must incorporate chronic care (Epping-Jordan et al. 2001) . Disease prevention policies traditionally implemented within the realm of the health sector now require multi-sectoral participation with strong stewardship from the Ministry of Health (Adeyi et al. 2007) . Some middle-income countries are responding to this challenge.
One way of gauging how well health systems are coping with the changing burden of disease is through the assessment of premature adult mortality. If living standards are improving and health policies are effective, mortality rates in the population aged 15-59 years should decline. A subset of deathsavoidable mortality, defined as deaths that should not occur if timely and effective medical care is available-should decline as much or more rapidly if the health care system is functioning properly and appropriate programmes are in place. Analysis of avoidable mortality has been used in several high-income countries (Rutstein et al. 1976; Charlton et al. 1983; Holland 1986; Nolte and McKee 2004) , but has been used less often in middle-income countries, perhaps because assessing all causes amenable to medical care can produce significant noise, since several infectious diseases are declining rapidly due to increasing standards of living, not necessarily due to effective medical care or prevention programmes. For this reason, we focus simply on NCD and contrast all-NCD mortality to avoidable-NCD mortality in order to assess the effect of NCD programmes.
In this paper, we describe NCD programmes and assess all-NCD mortality trends and avoidable-NCD mortality among adults aged 15-59 in three middle-income countries: Argentina, Chile and Uruguay. These countries have similar social and cultural backgrounds, similar levels of development, complete death registration and have undertaken several reforms of their health systems over the last 40 years. The programmes designed to prevent and treat NCD, however, differ across the three countries. Our hypothesis is that if NCD programmes exert no effect, then all-NCD mortality and avoidable-NCD mortality will follow the same trend and avoidable-NCD mortality will not change at a faster pace.
Methods

Health policies and programmes
Information on NCD programmes operating in each country was obtained from published reports and through publicly available official sources, such as the Ministry of Health or the Pan American Health Organization websites and special publications. After reviewing these sources, we created a template describing the relevant programmes and shared it with the head of the NCD programme (or equivalent) in each country. We conducted telephone interviews with each programme head to corroborate, expand the information and ask about other relevant programmes not documented in these sources. Our programme analysis begins in 1980, as there were few programmes focused on NCD operating in these countries prior to 1980.
Analysis of mortality
Mortality and population data were extracted from the World Health Organization (WHO) mortality database for the years 1970 to 2005, by 5-year age groups for males and females aged 15-59 years. The selection of this age group is consistent with the definition of adult mortality of the United Nations Population Division and the WHO. It represents the most economically productive age span and high NCD mortality at ages 15-59 can be considered a failure of the system. Deaths were coded according to the International Classification of Diseases 9th and 10th revisions (ICD-9 and ICD-10). All three countries are considered by the WHO to have 100% death registration, and medium quality accuracy, since ill-defined codes appeared in over 10% of their registered deaths in some years (Mathers et al. 2005 ). To ensure comparability over time, we reassigned ill-defined conditions (ICD-9 codes 780-799 and ICD-10 codes R00-R99) to a defined condition according to the relative frequency of known causes of deaths in the same age-sex group in each country (WHO 2009 ). The frequency of the known causes of deaths was based on the ICD-9 Basic Tabulation List and the ICD-10 Mortality Tabulation List-1 (WHO 2010).
We selected deaths attributed to NCD as stated in the Global Burden of Disease Study 2009 (WHO 2009 . Codes assigned to malignant neoplasms of other and unspecified sites (190) (191) (192) (193) (194) (195) (196) (197) (198) (199) and other diseases of the circulatory system (ICD-9, 440-459 and ICD-10, I95-I99) were reassigned within their respective categories based on frequency of defined causes. To account for changes in the classification that may affect trends, we used comparability ratios developed by the US National Center for Health Statistics (Anderson et al. 2001) . Causes of death considered avoidable are based on the list produced by Nolte and McKee (Nolte and McKee 2004 ), but we extracted only deaths attributable to NCD (Table 1) .
One of the problems with this list is the inclusion of ischemic heart disease, which can be affected by primary prevention as well as by health care interventions. We therefore conducted sensitivity analysis including and then excluding ischemic heart disease from avoidable-NCD mortality. To assess secular trends of smoking-related conditions we include trends of cancer of the trachea, bronchus and lung (ICD-9, 162, ICD-10 C33-C34), since smoking is the most important preventable risk factor for NCD and the single known cause that can significantly change lung cancer mortality at the population level. We assumed that mortality from lung cancer is not related to medical care because there is no evidence that treatment reduces mortality from this condition.
To compare all-NCD mortality rates with avoidable-NCD mortality rates, we calculated sex-specific, age-standardized rates using the population for South America in 2000 (United Nations Population Information Network 2010) as the standard population. We examined proportional change in mortality rates by comparing 5-year average age-standardized rates for two periods, 1980-84 and 2000-04, and assessed mortality trends between 1970 and 2005 by fitting the log of agestandardized mortality rates with a joinpoint regression model.
Joinpoint regression identifies points (years) where there is a statistically significant change (P < 0.05) in the slope of the linear trend. The analysis initially assumes that there are no changes (joinpoints) and iteratively fits models until a curve C00-C97, D00-D48, D55-D64 (minus D64.9), D65-D89, E03-E07, E10-E16, E20-E34, E63-E88, F01-F99, G06-G98, H00-H61, H68-H93, I00-I99, J30-J98, K00-K92, N00-N64, N75-N98, L00-L98, M00-M99, Q00-Q99 
Results
Health policies and programmes
In an effort to address the growing burden of NCD, Ministries of Health from each country have implemented nationwide programmes. Although smaller-scale interventions, demonstrations and research projects relating to NCD prevention and treatment have been conducted, Table 2 only includes programmes that involve a large proportion of the population, as these are most likely to have an impact on premature adult mortality.
Argentina
Over the years, the National Ministry of Health in Argentina has made efforts to co-ordinate disease control and prevention programmes in a highly fragmented health system with over 300 independent insurance schemes, which cover 47% of the population. The remainder of the population has access to public systems managed by the provinces (Pan American Health Organization 2007a). In the 1990s, a series of reforms increased the regulatory role of the State, and the National Ministry of Health began exerting greater co-ordination while expanding health coverage (Barrientos and Lloyd-Sherlock 2000; Centrangolo and Devoto 2002) . A programme dedicated to diabetes and hypertension focused on the development of national guidelines and the co-ordination of activities with provinces and health care providers. In 2000, the National Ministry of Health established a directorate to co-ordinate activities for the prevention and control of NCD, which organized existing NCD programmes into three main areas: surveillance, interventions in health services and health promotion (Table 2) . Recent programmes that were established after the study period that could have a large impact include a cervical cancer prevention programme (2008) and the creation of a National Cancer Institute in 2010 responsible for policy and research (Ministerio de Salud, Argentina 2010). Since 2005, the National Ministry of Health has tried to use provincial initiatives as models for national programmes. For example, it supported the expansion of a diabetes control programme that started in La Plata (Gagliardino et al. 2001 ) and now has extended to the rest of the country.
Although provincial autonomy poses barriers to the implementation of countrywide unified health policies, in the case of tobacco control, this autonomy has been beneficial. The Argentinean Congress has not ratified the Framework Convention for Tobacco Control (FCTC), which would require that Argentina implement explicit tobacco control policies; nonetheless, 11 out of 24 provinces have already implemented demand reduction provisions contained in the FCTC (Laspiur 2009 ).
Chile
Beginning in the early 1980s, the Ministry of Health of Chile realized the need to increase its efforts to prevent and control NCD, and launched programmes aimed at the identification and management of people with Type II diabetes and with hypertension. These programmes provided primary care services with evidence-based management guidelines, ensured continuity of care and extended coverage to include other professional services, such as nutrition counselling and foot care. In 2002, the hypertension and diabetes programmes were integrated into the Cardiovascular Health Programme, a broad programme targeting individuals with at least one of the following conditions: smoking, hypertension, diabetes or hypercholesterolemia (Escobar 2009) .
Following the restructuring of a cervical cancer screening programme in 1987, the proportion of women who reported being screened in the past 3 years increased from 45% in 1990 to 66% in 1996 (Sepulveda and Prado 2005) . By the mid 1990s, other cancer prevention and control components were added to create a national cancer control programme. These and other major NCD programmes in Chile were delivered through the public health care system that, in 1980, covered 60% of the population, but grew to cover 77% of the population by 2005. A new reform implemented in 2005 prioritized the prevention and treatment of 56 conditions, most of which are NCD. For each of these conditions, all Chilean residents have guaranteed timely access to services (Vargas and Poblete 2008) . Within the same year, the Ministry of Health launched a programme in primary care settings that focused on nutrition and physical activity. The extent of coverage for NCD is documented by a recent survey showing that nearly 84% of Chileans with a chronic condition were able to get the care they needed, but less than 4% of adults under age 60 reported a preventive visit in the previous year 
Uruguay
In the early 1980s, Uruguay created the National Resource Fund to administer funding for specialized health interventions, 
Mortality analysis
Over the period of study, in the three countries avoidable mortality from NCD declined slightly less than all-NCD mortality. From 1980-84 to 2000-04, premature mortality from all NCD decreased by over 50% in Chile, 40% in Argentina and 34% in Uruguay, while avoidable-NCD mortality decreased by only 38% in Chile, 35% in Argentina and 32% in Uruguay.
The proportional change in the decline of all-NCD mortality was larger among females than males, whereas the change in avoidable-NCD mortality was larger among males than females in Argentina and Uruguay (Table 3) . In Argentina, avoidable-NCD mortality declined by 38.4% among males and by 30.5% among females. In Uruguay, avoidable-NCD mortality declined by 37% among males and by 27.3% among females, but in Chile the decline was slightly higher among females than among males: 40.4% vs 37.2%.
In response to the debate over whether declines in premature mortality from ischemic heart disease should be attributed to health care interventions or to reductions in the incidence of disease, we tested the exclusion of ischemic heart disease from avoidable-NCD mortality. In Argentina and Uruguay, this led to a decline in the proportional change of avoidable-NCD mortality among males, approximating the change observed among females, suggesting that a reduction in the incidence of ischemic heart disease among males has occurred. One of the main risk factors to influence declines in incidence of ischemic heart disease is smoking. Lung cancer, which is a tracer for smoking-related diseases, declined among males, but increased among females in all three countries during the period of study. The largest proportional change in lung cancer mortality occurred in Uruguay, where from 1980-84 to 2000-04 mortality declined by 60.2% among males and increased by 117.6% among females.
Time trends are displayed in graphs (Figure 1 ) depicting mortality rates for all NCD and for avoidable NCD that excludes ischemic heart disease (IHD-excluded). The scale on the y axis on the left measures all-NCD mortality and the scale on the right measures avoidable-NCD mortality (IHD-excluded). The circles represent the starting year of each programme.
In Argentina (Panel A), mortality from NCD declined at a moderate pace from 1980 to 1992-94, with an AAPC À1.7 (95% confidence interval À2.1, À1.3) for males and À2.2 (95% confidence interval À2.6, À1.8) for females. Until 1994, avoidable-NCD mortality (IHD-excluded) declined at a slightly faster pace than all-NCD mortality among males. After 1994, avoidable-NCD mortality (IHD-excluded) experienced a moderate increase in its pace of change with an AAPC of À2.4, while all-NCD mortality shows an even faster decline at an AAPC of À3.9. Among females, the pace of change in mortality from all NCD also increased after 1992 to an AAPC of À3.5, and although it increased for avoidable-NCD mortality from À0.7 (95% confidence interval À0.9, À0.4) to À2.1 (95% confidence interval À2.4, À2.0), all-NCD mortality declined faster. As depicted by the symbols in the graphs, NCD programmes were initiated in the early 1990s. , 1970-2005 In Chile (Panel B), all-NCD mortality declined from 1983 to 1996 at an AAPC of À3.4 (95% confidence interval À4.5, À2.3) among males and À3.3 (95% confidence interval À3.0, À2.6) among females, but as of 1998-99 the pace of change decreased to an AAPC of À1.4 in males and À2.3 in females. At the same time, avoidable-NCD mortality (IHD-excluded) decreased at a steady pace throughout the 1980s until 2005. AAPC was À2.4 for males and À2.6 for females. The three NCD programmes initiated in the 1980s and 1990s coincide with inflection points on the graphs.
From 1980 to 1994 Uruguay experienced little decline in all-NCD mortality (Panel C); AAPC among males was À0.5 (95% confidence intervals À1.2, 0.3) and À1.1 (95% confidence intervals À1.6, À0.6) among females. As of 1994, the pace of change for all-NCD mortality increased to an AAPC of À4.2 among males, but stagnated among females at 0.4. Avoidable-NCD mortality (IHD-excluded), on the other hand, has been steadily declining among males (AAPC À1.5) and females (AAPC À1.3) since the 1970s. However, this pace of change for avoidable-NCD mortality (IHD-excluded) has been significantly slower than that of Argentina and Chile.
Data presented in Table 4 confirm that avoidable-NCD and all-NCD mortality do not show significant difference in the pace of change among males in Argentina and females in Chile. All-NCD mortality declined slightly faster than avoidable-NCD mortality among females in Argentina and among males in Uruguay. The contrary occurs among Chilean males and Uruguayan females, in whom all-NCD mortality has stagnated but avoidable-NCD mortality maintains a steady decline, albeit confidence intervals are overlapping. Argentina and Chile show similar decline in avoidable-NCD mortality and no changes are seen upon excluding ischemic heart diseases in either country. In Uruguay, however, among males the pace of change decreases significantly from an AAPC of À2.2 to an AAPC of À1.5 per year (P < 0.05) when ischemic heart disease is excluded from avoidable-NCD mortality.
The effect of smoking-related diseases represented by lung cancer mortality also shows gender differences. In Uruguay the AAPC is À1.9 among males and þ2.8 among females. In Chile, lung cancer mortality is also declining among males, with an AAPC of À2.6, but is stable among females (AAPC of þ0.2). The contrast is largest in Argentina, where the pace of change is À3.1 in males and þ2.6 in females.
Our sensitivity analysis, which was conducted to assess the sensitivity of our findings to the definition of adult mortality, shows that from 1980-84 to 2000-04, the direction of proportional change of the 5-year average mortality rates are the same for 15-59 year olds as for 60-74 year olds. However, the magnitude of the change is slightly lower among the latter, particularly for avoidable-NCD mortality (IHD-excluded) in males and for lung cancer mortality (Table 5 ). The trend analysis among 60-74 year olds (Table 6 ) is consistent with the results for 15-59 year olds in Argentina. The decline in all-NCD mortality in Chile is more pronounced (higher AAPC) among 60-74 year olds than among 15-59 year olds. In the older age group, all-NCD mortality is declining significantly faster than avoidable-NCD mortality among females, but no significant differences are observed among males. In Uruguay, mortality Table 4 Average annual percentage change since the latest change in trend for all-NCD mortality, avoidable-NCD mortality and lung cancer mortality among adults aged 15-59 in Argentina, Chile and Uruguay
Males Females
Last joinpoint (95% confidence interval)
Average annual percentage change since last joinpoint (95% confidence interval)
Average annual percentage change since last joinpoint (95% confidence interval) trends among 60-74 year olds are the opposite of those of 15-59 year olds. For males aged 60-74, the pace of change of all-NCD mortality has stagnated at À0.3 and there is no difference with the trend observed for avoidable-NCD mortality. Among 60-74 year old Uruguayan females, all-NCD mortality has declined faster than avoidable-NCD mortality, which has stagnated since the mid 1990s.
Argentina
Discussion
By assessing adult premature mortality trends in Argentina, Chile and Uruguay, and describing the NCD programmes in these countries, we can point towards improvements in population health and towards areas of weaknesses. During the study period, avoidable-NCD mortality maintained a steady decline among 15-59 year olds in all three countries, which suggests that the advent of NCD health-care-based programmes had a positive effect on reducing the mortality rate for NCD. This observation is reinforced in Argentina and among Chilean females, where 60-74 year olds show the same mortality trends as younger adults.
The continuous decline in avoidable-NCD mortality amid the stagnation of all-NCD mortality among males in Chile and females in Uruguay further speaks to the positive effect of programmes delivered through health care. However, among 60-74 year olds in Uruguay, the stagnation of NCD mortality in males and of avoidable-NCD mortality (IHD-excluded) in both sexes indicates that deaths prevented in younger adults may be displaced towards the 60-74 age group. The changing relationships between avoidable-NCD mortality and all-NCD mortality declines suggest that complex interactions are occurring between mortality reduction and changes in disease incidence.
Changing incidence of NCD
Reductions in the pace of change or stagnation of all-NCD mortality, such as is seen in Chile and among females in Uruguay, could be due to either decreased standards of living or increased incidence of diseases not avoided through health care. Yet, from 1980 to 2005, standards of living in these countries improved, as indicated by a rise in gross national income per capita of 312% in Chile and 200% in Uruguay, as well as improvement in other social indicators (World Bank 2010). In addition, there is no reason why changes in standards of living would affect males and females differently, as seems to be the case in Uruguay. Therefore, it is likely that increased incidence of NCD among adults aged 15-59 could be contributing to the stagnation of mortality rates.
According to estimates from the Burden of Disease study, changes in the rates of smoking, obesity and alcohol consumption are three key risk factors that may be contributing to the increasing incidence of NCD in Argentina, Chile and Uruguay (WHO 2009). In 2008, WHO reported that the age standardized percentages of daily smokers were highest in Chile (40.1% for males and 32.8% for females), followed by Uruguay (34.3% in males and 24.2% in females), and lowest in Argentina (27% in males and 21.1% in females) (WHO 2008) . Argentinean and Uruguayan females show increasing lung cancer mortality, but they have a lower prevalence of smoking than Chilean females. Descriptions of the dynamics of the tobacco epidemic in developed countries indicate that lung cancer mortality rates start increasing several years after the prevalence of smoking increases and peaks several years after the prevalence of smoking starts to decline (Lopez 1990 Federation 2009 ). This suggests that the moderate obesity rates are a relatively recent phenomenon, the impact of which has yet to be fully realized. Unfortunately, data on the prevalence of alcohol abuse are not comparable across the three countries.
Population-based prevention programmes that target risk factors for NCD and are implemented across various sectors were brought to scale only towards the end of the study period. In 2001, Argentina initiated a programme based on public health surveillance and local interventions for NCD prevention and health promotion, and in 2005, Uruguay and Chile expanded their tobacco control programmes. If these programmes are effective, the decline in all-NCD premature mortality may be expected to accelerate in the future.
The influence of health care
Avoidable-NCD mortality declined faster among younger and older adults in Argentina and Chile than in Uruguay. This may be due to differing levels of coverage and/or quality of health care in these countries. Another possible explanation is that, in Uruguay, early NCD programmes favoured secondary and tertiary care interventions, such as dialysis and complex surgery, whereas those of Argentina and Chile were designed to be implemented through primary care services, which may have been more effective. A faster decline in avoidable-NCD mortality than all-NCD mortality signals that the health care network may be a good vehicle for NCD interventions. However, teasing out whether this is due to access to care or to the overall quality of these services is nearly impossible based on mortality data alone. The NCD programmes implemented by the Ministries of Health may have contributed to create standards across the health care system and to focus on critical issues, such as continuous care for people with diabetes or hypertension in Chile.
Since 1998, the pace of change in all-NCD premature mortality among females in Chile slowed down to the same level as avoidable-NCD mortality. There are two possible explanations for this effect. One is that following the decrease in the change of pace of all-NCD mortality, the only effect remaining is that exerted by interventions delivered through health care. Alternatively, it may imply that NCD health care is not contributing to an additional mortality decline. To further isolate the effect of health care, we excluded ischemic heart disease from avoidable-NCD mortality. Changes in mortality from this condition can be influenced by decreased incidence of the disease or by medical care interventions. The effect of excluding ischemic heart disease was negligible in Chile, indicative of the strong role of health care. Conversely, among males in Uruguay, the pace of change was significantly lower when we excluded ischemic heart disease from avoidable-NCD mortality. This reflects the influence of ischemic heart disease on NCD mortality decline, a phenomenon also seen in developed countries (O'Hara et al. 2008) , but it also reveals a diminished role of NCD health-care-based programmes in Uruguay.
Comparison with other studies
A global study of adult premature mortality that used indirect estimates also showed a decline in mortality for these three countries (Rajaratnam et al. 2010) . According to these data, the current level of premature adult mortality in Argentina, Chile and Uruguay is similar to that of other countries of Latin America with high coverage of their health systems, such as Colombia and Costa Rica. Yet, it is still at least 25% higher than premature adult mortality in developed countries such as Canada, the United Kingdom, the Nordic countries and Spain. This global study, however, did not disaggregate by causes of death. Restricting our analysis to NCD eliminated the noise introduced by the decline in infectious diseases due to increased living standards. Another study in developed countries compared avoidable mortality in two periods using proportional change in mortality (Nolte and McKee 2008) . With our trend analysis, it was possible to compare not only the total change but also the annual pace of change and to identify inflection points in the course of mortality decline. We also were able to describe the NCD programmes that countries have implemented, which helps link the results to a policy dialogue.
Limitations
Our study is subject to the limitations of all analyses of mortality trends. Firstly, changes in coding rules of the International Classification of Disease and changes in diagnostic practices can affect mortality trends. We corrected by re-assigning ill-defined causes and unspecified causes within categories, and by using a correction factor. However, this tool is not specific for these countries and some misclassification of disease may have remained. Second, mortality is a late indicator of the health situation; it only provides an approximation of the overall health status. Yet, in the absence of longitudinal data on morbidity and on use of health services, it is the best reliable source in many middle-income countries. Third, the selection of avoidable NCD is subject to judgment. We used a list that has been used in several European countries and the United States (Nolte and McKee 2003) ; furthermore, our selection of NCD coincides with previous lists also used in developed countries (Charlton et al. 1983; Holland 1986 ), but it can still be questioned whether it is applicable to middle-income countries. Fourth, as with any analysis of group data, it cannot be assumed that findings apply to all individual members of that group. Lastly, avoidable mortality is an aggregate measure; therefore, to further interpret the trends, disaggregated causespecific mortality is necessary, which is best done country by country and is beyond the scope of this paper. A mortality analysis is not an evaluation of the effectiveness of the health system or of its policies and programmes, but it points to areas that require additional investigation.
Conclusion
The continuous decline in avoidable-NCD mortality amid the stagnation of all-NCD mortality among males in Chile and females in Uruguay suggests that those programmes delivered through health care may have a beneficial effect on population health outcomes. Early NCD programmes in Argentina and Chile were designed to be delivered through primary care, which could be associated with the steady decline in mortality from NCD avoidable through medical care. Although, factors outside the health care system may be influencing the changes observed in NCD mortality trends in these countries, it was only after the year 2000 that population-based NCD prevention programmes, such as tobacco control, were brought to scale. When programme evaluations and information on outcomes of NCD programmes are not available, researchers can use all-NCD mortality and avoidable premature mortality for a preliminary assessment of the effect of NCD programmes.
